Search

352 Result(s)
Sort by

A Deep Dive into Wet AMD

A Deep Dive into Wet AMD

Wet AMD is a disease of the central portion of the retina (the macula) which is responsible for high visual acuity that allows for color vision, reading and facial recognition
SIRPα Cancer Immunology Research

SIRPα Cancer Immunology Research

Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Knowing the enemy: PRRS and PCVD

Knowing the enemy: PRRS and PCVD

The swine industry is constantly vigilant of viruses such as PRRS and PCV2 (PCVD). Learn about prevention, symptoms knowledge, and control measures to make a difference.
Be Green Brazil – powered by nature

Be Green Brazil – powered by nature

At Boehringer Ingelheim’s Solana farm Adrian von Treuenfels and his team cultivate the plants that supply the active ingredient for different drugs.
Geographic Atrophy

Geographic Atrophy

Geographic Atrophy is a slowly progressing, yet damaging form of AMD. Approximately 5 million people have Geographic Atrophy worldwide, with disease prevalence increasing with age. It is characterized by regions of cell death in the retina.
Stargardt Disease

Stargardt Disease

Stargardt Disease is a hereditary condition causing and progressive vision loss, typically during childhood or adolescence.
The METAmorphosis

The METAmorphosis

At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic.
Harold Heart and Heart Failure

Harold Heart and Heart Failure

People with heart failure may experience a significant physical, social and emotional impact on their daily life, and can feel out of breath doing simple activities
1885-1948: Innovative beginnings

1885-1948: Innovative beginnings

The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products
NeO - smart and sustainable vaccines

NeO - smart and sustainable vaccines

The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.
Be green Japan

Be green Japan

Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply.
Biotherapeutics Discovery

Biotherapeutics Discovery

We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.